Xiao-Yan Zhou

2.2k citations
44 papers · 1.9k indexed · h-index 23
Topics
Lymphoma Diagnosis and Treatment (10 papers)RNA modifications and cancer (8 papers)Genetic factors in colorectal cancer (7 papers)

In The Last Decade

Xiao-Yan Zhou

44 papers receiving 1.9k citations

Peers

Xiao-Yan Zhou
Comparison fields: 5 of 95
  • Molecular Biology 1.0k
  • Cancer Research 819
  • Oncology 389
  • Pathology and Forensic Medicine 297
  • Immunology 230
Replace Karl‐Ludwig Schaefer with:
Karl‐Ludwig Schaefer Germany
Camila Avivi Israel
Karl Köchert Germany
Juliette A. Randerson‐Moor United Kingdom
A. Kretzschmar Germany
Takayuki Yamada Japan
Gülnur Güler Türkiye
Mutsumi Ohe-Toyota Japan
Vasiliki Koliaraki Greece
Ralf‐Peter Czekay United States
Xiao-Yan Zhou relative to Karl‐Ludwig Schaefer Germany Karl‐Ludwig Schaefer's profile →
Citations per field
00.5×2.9×
Karl‐Ludwig Schaefer · 1×
Citations per year

Countries citing papers authored by Xiao-Yan Zhou

Since Specialization
Citations

This map shows the geographic impact of Xiao-Yan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Yan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Yan Zhou more than expected).

Fields of papers citing papers by Xiao-Yan Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao-Yan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Yan Zhou. The network helps show where Xiao-Yan Zhou may publish in the future.

Co-authorship network of co-authors of Xiao-Yan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao-Yan Zhou. A scholar is included among the top collaborators of Xiao-Yan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao-Yan Zhou. Xiao-Yan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 248
2 20
3 28
4 12
5 55
6 61
7 26
8 29
9 38
10 7
11 25
12 115
13 30
14 32
15 4
16 50
17 22
18 32
19 32
20 17

About Xiao-Yan Zhou

Xiao-Yan Zhou is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research, having authored 44 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), RNA modifications and cancer (8 papers) and Genetic factors in colorectal cancer (7 papers). The work is most often cited by research in Cancer Research (819 citations), Hematology (228 citations) and Genetics (189 citations). Xiao-Yan Zhou has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Xiang Du, Peng Qi, Mi‐die Xu, Shu-juan Ni, Cong Tan, Dan Huang, Meng-Hong Sun, Jing He, Li‐Xin Qiu and Abdül Waheed. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026